Diagnostic status and treatment recommendations for Persian Gulf War veterans with multiple nonspecific symptoms

Military Medicine

Volumn 166, Issue 11, 2001, Pages 972-981

  Baker, D G ^a   McQuarrie, I G ^a   Murray, M G ^a   Lund, L M ^a   Dashevsky, B A ^a   Mendenhall, C L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; COMORBIDITY; FEMALE; FIBROMYALGIA; HAMILTON SCALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PERSIAN GULF SYNDROME; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; QUALITY OF LIFE; SOLDIER; SYMPTOMATOLOGY;

EID: 0035148986     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/166.11.972     Document Type: Article

References (49)

1. The Persian Gulf experience and health
2. Gulf War illness
3. Is there a Gulf War syndrome? Searching for syndromes by factor analysis of symptoms
4. Evaluation of neurologic function in Gulf War veterans: A blinded case-control study
5. Self-reported exposure to neurotoxic chemical combinations in the Gulf War: A cross-sectional epidemiologic study
6. Health of UK servicemen who served in Persian Gulf War
7. Health status of Persian Gulf War veterans: Self-reported symptoms, environmental exposures and the effect of stress
8. Medical mystery Gulf War syndrome
9. Clinical findings for the first 1000 Gulf War veterans in the Ministry of Defence's medical assessment programme
10. Symptoms in 18,495 Persian Gulf War veterans: Latency of onset and lack of association with self-reported exposures
11. Mortality among U.S. veterans of the Persian Gulf War
12. Are Gulf War veterans suffering war-related illness?
13. Chronic multi-symptom illness affecting Air Force veterans of the Gulf War
14. Is there a Gulf War syndrome?
15. Letter to the editor
16. Identification of Gulf War syndrome: Methodological issues and medical illnesses
17. Letter to the editor
18. Is there a Gulf War syndrome?
19. Signs, symptoms and ill-defined conditions in Persian Gulf War veterans: Findings from the comprehensive clinical evaluation program
20. Self-reported illness and health status among Gulf War veterans
21. The psychometric properties of the Composite International Diagnostic Interview
22. Clinical evaluation of a measure to assess combat exposure
23. Mississippi Scale for Combat-Related Post-Traumatic Stress Disorder: Three studies in reliability and validity
24. The development of a clinician-administered PTSD scale
25. A rating scale for depression
26. An inventory for measuring depression
27. The Fibromyalgia Impact Questionnaire: Development and validation
28. The MOS 36-Item Short-Form Health Survey. II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
29. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study
30. Health-related quality of life in parents served by the Department of Veterans Affairs: Results from the Veterans Health Study
31. Gulf War veterans' health registries: Who is most likely to seek evaluation?
32. The health status of Gulf War veterans: Lessons learned from the Department of Veterans Affairs health registry
33. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
34. Post-traumatic stress disorder in the National Comorbidity Survey
35. Psychological and war stress symptoms among deployed and non-deployed reservist following the Persian Gulf War
36. A comprehensive clinical evaluation of 20,000 Persian Gulf War veterans
37. Preliminary evidence of psychological distress among reservists in the Persian Gulf War
38. Relationship of psychiatric status of Gulf War veterans' health problems
39. The effects of adherence of antidepressant treatment guidelines on relapse and recurrence of depression
40. Fluoxetine in post-traumatic stress disorder: Randomized double-blind study
41. Quality of life and posttraumatic stress disorder: A pilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of fluoxetine
42. Double-blind, placebo-controlled study of the efficacy and safety of sertraline treatment of posttraumatic stress disorder
43. The psychological dimensions of health care for patients exposed to radiation and other invisible environmental contaminants
44. Psychological factors affecting health after toxicological disasters
45. Depressive and anxiety disorders in patients presenting with physical complaints: Clinical predictors and outcome
46. Difficult patient encounters in the ambulatory clinic